Baseline characteristics and outcome of patients in low dose and high dose snake antivenom group
| Low dose group | High dose group | |||
|---|---|---|---|---|
| SAV, snake antivenom, RICU, respiratory intensive care unit. | ||||
| Number of patients | 28 | 27 | ||
| Male/female | 25/3 | 23/4 | ||
| Mean (SD) age, years | 28.3 (14.5) | 32.2 (14.8) | ||
| Delay in presentation after bite, hours | 6.9 (5.6) | 6.5 (4.5) | ||
| Local signs and symptoms | 3 (10.7) | 4 (14.8) | ||
| Snakebite fang marks | 22 (78.6) | 21 (77.8) | ||
| Median SAV dose (range), ml | 150 | 600 (300 to 1600) | ||
| Median extubation time (range), hours | 47.5 (14 to 248) | 44 (12 to 400) | ||
| Mean (SD) RICU stay, days | 3.9 (2.0) | 3.9 (3.0) | ||
| Mortality | 0 | 3 (11.1) | ||